tiprankstipranks
Trending News
More News >
Percheron Therapeutics Limited (AU:PER)
:PER
Australian Market

Percheron Therapeutics (PER) Income Statement

Compare
13 Followers

Percheron Therapeutics Income Statement

Last quarter (Q4 2025), Percheron Therapeutics's total revenue was AU$0.00, a decrease of ― from previous quarter. In Q4, Percheron Therapeutics's net income was AU$-6.39M. See Percheron Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Gross Profit
AU$ -67.98KAU$ -79.42KAU$ -95.20KAU$ -89.22KAU$ -103.32K
Operating Expenses
AU$ 16.64MAU$ 14.80MAU$ 13.25MAU$ 7.52MAU$ 8.58M
Depreciation and Amortization
AU$ 67.98KAU$ 79.42KAU$ 95.20KAU$ 89.22KAU$ 103.32K
EBITDA
AU$ -16.27MAU$ -11.84MAU$ -13.25MAU$ -7.52MAU$ -8.58M
Operating Income
AU$ -16.71MAU$ -14.88MAU$ -13.34MAU$ -7.61MAU$ -8.68M
Other Income/Expenses
AU$ 356.16KAU$ 608.89KAU$ 385.30KAU$ 21.52KAU$ 44.88K
Pretax Income
AU$ -16.35MAU$ -14.27MAU$ -12.96MAU$ -7.59MAU$ -8.64M
Net Income
AU$ -14.92MAU$ -11.92MAU$ -11.38MAU$ -5.81MAU$ -8.06M
Per Share Metrics
Basic EPS
AU$ -0.01AU$ -0.02AU$ -0.02AU$ -0.01AU$ -0.01
Diluted EPS
AU$ -0.01AU$ -0.02AU$ -0.02AU$ -0.01AU$ -0.01
Weighted Average Shares Outstanding
1.02B 669.03M 669.03M 634.29M 540.98M
Weighted Average Shares Outstanding (Diluted)
1.02B 669.03M 669.03M 634.29M 540.98M
Currency in AUD

Percheron Therapeutics Earnings and Revenue History